Holen Sie sich die Stockscreener-App
2.42
13.62%
0.29
Handel nachbörslich:
2.42
Schlusskurs vom Vortag:
$2.13
Offen:
$2.17
24-Stunden-Volumen:
311.13K
Relative Volume:
1.05
Marktkapitalisierung:
$8.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.47M
KGV:
-4.84
EPS:
-0.5
Netto-Cashflow:
$-13.51M
1W Leistung:
+28.04%
1M Leistung:
+15.24%
6M Leistung:
+5.22%
1J Leistung:
-67.90%
1-Tages-Spanne:
$2.13
$2.50
1-Wochen-Bereich:
$1.8633
$2.50
52-Wochen-Spanne:
$1.30
$7.44
Nls Pharmaceutics Ltd Stock (NLSP) Company Profile
Firmenname
Nls Pharmaceutics Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie NLSP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NLSP
Nls Pharmaceutics Ltd
|
2.42 | 10.45M | 0 | -15.47M | -13.51M | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Nls Pharmaceutics Ltd Aktie (NLSP) Neueste Nachrichten
How NLS Pharmaceutics AG stock performs during market volatility2025 Price Momentum & Short-Term Trading Alerts - Newser
Published on: 2025-08-12 23:45:07 - Newser
How to escape a deep drawdown in NLS Pharmaceutics AGBreakout Stock Opportunities with Low Drawdown - Newser
What machine learning models say about NLS Pharmaceutics AG Equity WarrantBuy Zone Strategy with Pattern Recognition - Newser
How NLS Pharmaceutics AG stock reacts to Fed policy changesControlled Entry Strategy With Safety Analytics - Newser
NLS Pharmaceutics Regains Compliance With Nasdaq Stockholders' Equity Requirement - 富途牛牛
Using data models to predict NLS Pharmaceutics AG stock movementFree Entry Alert With Low Drawdown Strategy - Newser
Is NLS Pharmaceutics AG Equity Warrant still worth holding after the dipForecasting Stock Moves with AI Insights - Newser
Can technical indicators confirm NLS Pharmaceutics AG’s reversalRSI and MACD Signal Summary with Trends - Newser
Developing predictive dashboards with NLS Pharmaceutics AG Equity Warrant dataFree Weekly Setup With 3x Return Potential - Newser
Building trade automation scripts for NLS Pharmaceutics AGFree Smart Trade Plans With Risk Protection - Newser
Can trapped investors hope for a rebound in NLS Pharmaceutics AGWeekly Growth Portfolio Performance Summary - Newser
NLS Pharmaceutics Enters Warrant Exchange Agreement with Alpha Capital - TipRanks
Custom watchlist performance reports with NLS Pharmaceutics AGFree Fundamental Winners With Safe Entry Plan - Newser
Analyzing NLS Pharmaceutics AG with multi timeframe chartsFree Early Entry Tips With Low Risk Zone - Newser
Can momentum traders help lift NLS Pharmaceutics AG Equity WarrantLow Risk Stock Trade Opportunity Analysis - Newser
Volume spikes in NLS Pharmaceutics AG stock – what they meanTrend Confirmation Scanner with Entry Focus - Newser
Why NLS Pharmaceutics AG stock attracts strong analyst attentionFree Early Entry Tips With Low Risk Zone - Newser
Does NLS Pharmaceutics AG Equity Warrant stock pay reliable dividendsFree Stock Market Watch With Alerts - Newser
How many analysts rate NLS Pharmaceutics AG as a “Buy”Achieve fast wealth growth with smart picks - Jammu Links News
What are the latest earnings results for NLS Pharmaceutics AGMassive wealth growth - Jammu Links News
How does NLS Pharmaceutics AG compare to its industry peersSky-high profits - Jammu Links News
NLS Pharmaceutics Announces Merger with Kadimastem and Secures $25 Million Financing Facility - AInvest
How does NLS Pharmaceutics AG Equity Warrant generate profit in a changing economyDaily Trading Alerts For Every Investor - Jammu Links News
Is This the Dip to Buy in NLS Pharmaceutics AGChart Breakout Buy Signal Detection Confirmed - beatles.ru
Institutional scanner results for NLS Pharmaceutics AG Equity WarrantAI Trend Detection for Entry Timing - Newser
How strong is NLS Pharmaceutics AG company’s balance sheetMarket Forecast Outlook With Proven Results - Jammu Links News
NLS Pharmaceutics AG Inches Above Key Support — Safe to HoldMarket Surge Signal for Swing Traders Triggered - metal.it
Can technical indicators confirm NLS Pharmaceutics AG Equity Warrant’s reversal - Newser
Will NLS Pharmaceutics AG Equity Warrant stock recover after recent dropSwing Entry Risk Mitigation with Chart Analysis - Newser
NLS Pharmaceutics (NASDAQ:NLSP) Shares Up 2% – Should You Buy? - Defense World
Sector Leaders Rotate Capital Into NLS Pharmaceutics AGProfit Focused Stock Screener Results Released - metal.it
Published on: 2025-07-28 23:38:35 - metal.it
Risk vs reward if holding onto NLS Pharmaceutics AG Equity WarrantShort-Term Market Movement Forecast Report - Newser
Does NLS Pharmaceutics AG Equity Warrant stock perform well during market downturnsConsistently high yield - Jammu Links News
What is the dividend policy of NLS Pharmaceutics AG stockGet timely alerts on market opportunities - Jammu Links News
What is the risk reward ratio of investing in NLS Pharmaceutics AG Equity Warrant stockAI Powered Tracker That Work - jammulinksnews.com
Is it the right time to buy NLS Pharmaceutics AG stockUnlock exclusive trading strategies for gains - Jammu Links News
Should I hold or sell NLS Pharmaceutics AG Equity Warrant stock in 2025Get daily updates on the hottest stocks - jammulinksnews.com
What makes NLS Pharmaceutics AG Equity Warrant stock price move sharplyInvest smarter with data-backed trading alerts - jammulinksnews.com
How volatile is NLS Pharmaceutics AG stock compared to the marketFastest return on investment - Jammu Links News
What drives NLS Pharmaceutics AG Equity Warrant stock priceFree Stock Movement Tracking - PrintWeekIndia
Is NLS Pharmaceutics AG a good long term investmentSky-high profits - PrintWeekIndia
What risks could impact NLS Pharmaceutics AG Equity Warrant stock performanceRapid Gain Targets - Newser
What drives NLS Pharmaceutics AG stock priceBreakout portfolio performance - jammulinksnews.com
What analysts say about NLS Pharmaceutics AG Equity Warrant stockTremendous growth opportunities - Autocar Professional
What analysts say about NLS Pharmaceutics AG stockExceptional portfolio growth - jammulinksnews.com
Is NLS Pharmaceutics AG Equity Warrant a good long term investmentPhenomenal capital gains - jammulinksnews.com
NLS Pharmaceutics Amends Merger Agreement with Kadimastem - TipRanks
Finanzdaten der Nls Pharmaceutics Ltd-Aktie (NLSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):